Goldman Sachs
ULBI icon

Goldman Sachs’s Ultralife ULBI Stock Holding History

Goldman Sachs’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,570
Closed -$244K – 6998
2025
Q4 		$244K Buy
42,570
+19,164
+82% +$118K ﹤0.01% 5961
2025
Q3 		$160K Buy
+23,406
New +$177K ﹤0.01% 5995
2025
Q2 		– Sell
-15,354
Closed -$82.6K – 6434
2025
Q1 		$82.6K Sell
15,354
-11,668
-43% -$79.3K ﹤0.01% 5824
2024
Q4 		$201K Buy
27,022
+6,265
+30% +$51.5K ﹤0.01% 5645
2024
Q3 		$188K Sell
20,757
-14,283
-41% -$147K ﹤0.01% 5476
2024
Q2 		$372K Sell
35,040
-3,952
-10% -$42.1K ﹤0.01% 4985
2024
Q1 		$344K Buy
+38,992
New +$317K ﹤0.01% 4914
2020
Q4 		– Sell
-22,893
Closed -$135K – 5715
2020
Q3 		$135K Buy
22,893
+7,424
+48% +$48.8K ﹤0.01% 5019
2020
Q2 		$108K Buy
+15,469
New +$113K ﹤0.01% 4972
2019
Q2 		– Sell
-53,870
Closed -$553K – 5359
2019
Q1 		$553K Buy
+53,870
New +$483K ﹤0.01% 4376

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Goldman Sachs's ULBI Position: Q1 2026 in Review

Goldman Sachs sold out of Ultralife (ULBI) in Q1 2026, closing a stake of 42,570 shares — an estimated $244K sold.

Goldman Sachs first reported a position in ULBI in Q1 2019 and held it in 10 quarters. The position peaked at $553K in Q1 2019. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.

  • Goldman Sachs reported no remaining Ultralife position as of Q1 2026 after selling out during the quarter.
  • Goldman Sachs sold 42,570 Ultralife shares in Q1 2026, an estimated $244K.
  • Goldman Sachs first reported a position in Ultralife in Q1 2019 and held it in 10 quarters.
  • Goldman Sachs's Ultralife position peaked at $553K in Q1 2019.
  • 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.